The Institute for Clinical and Economic Review (ICER) is scheduled to host a three-part series focused on drug pricing during a pandemic.
The first session, which will discuss cost-recovery pricing, is set for noon EST July 24.
Confirmed speakers include:
- Afton Cissell, JD, Senior Counsel to Congressman Lloyd Doggett (D-Tex);
- Ronny Gal, Analyst, Sanford C. Bernstein;
- David Mitchell, Founder, Patients For Affordable Drugs; and
- Aaron Kesselheim, MD, JD, MPH, Professor of Medicine, Brigham and Women’s Hospital/Harvard Medical School.
ICER’s series was announced alongside its latest white paper, “Alternative Policies for Pricing Novel Vaccines and Drug Therapies for COVID-19.”
To learn more about this event, click here.
To read the white paper, click here.